Logos Global Management’s Ascendis Pharma A/S ASND Stock Holding History

Logos Global Management’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-150,000	Closed	-$16.1M	–	53
2023 Q1	$16.1M	Buy	+150,000	New	+$17.2M	2.3%	16
2022 Q4	–	Sell	-250,000	Closed	-$25.8M	–	42
2022 Q3	$25.8M	Buy	+250,000	New	+$23.7M	3.17%	14
2022 Q2	–	Sell	-175,000	Closed	-$20.5M	–	34
2022 Q1	$20.5M	Buy	+175,000	New	+$20.3M	2.66%	18
2020 Q2	–	Sell	-120,000	Closed	-$13.5M	–	49
2020 Q1	$13.5M	Sell	120,000 -59,898	-33%	-$7.78M	5.14%	5
2019 Q4	$25M	Buy	+179,898	New	+$20M	6.17%	5

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Logos Global Management's ASND Position: Q2 2023 in Review

Logos Global Management sold out of Ascendis Pharma A/S (ASND) in Q2 2023, closing a stake of 150,000 shares — an estimated $16.1M sold.

Logos Global Management first reported a position in ASND in Q4 2019 and held it in 5 quarters. The position peaked at $25.8M in Q3 2022. 158 funds tracked by Wall St. Rank hold ASND as of Q2 2023.

Logos Global Management reported no remaining Ascendis Pharma A/S position as of Q2 2023 after selling out during the quarter.
Logos Global Management sold 150,000 Ascendis Pharma A/S shares in Q2 2023, an estimated $16.1M.
Logos Global Management first reported a position in Ascendis Pharma A/S in Q4 2019 and held it in 5 quarters.
Logos Global Management's Ascendis Pharma A/S position peaked at $25.8M in Q3 2022.
158 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2023.

Based on Logos Global Management's 13F filing for Q2 2023, filed 14 Aug 2023.